Searchable abstracts of presentations at key conferences in endocrinology

ea0035p380 | Diabetes (epidemiology, pathophysiology) | ECE2014

Anthropometric and biochemical parameters in older women with a history of gestational diabetes

Topsakal Senay , Akin Fulya , Yaylali Guzin F

Introduction: Gestational diabetes mellitus (GDM) is a condition that occurs during pregnancy when the body cannot produce enough insulin to handle the effects of a growing baby and changing hormone levels. Numerous studies reported that an increased risk of GDM among women who are overweight or obese compared with lean or normal-weight women.Methods/design: The purpose of this study is to compare anthropometric and biochemical parameters in postmenopaus...

ea0035p1027 | Thyroid (non-cancer) | ECE2014

DHEAS Levels in Obese Patients with Hashimato Thyroiditis

Topsakal Senay , Akin Fulya , Yaylali Guzin F

Introduction: It is well known association between cardiovascular disease and PCOS. Approximately 17–43% of women with PCOS have hyperprolactinemia. Increased levels of prolactin often associated with an increased risk for thromboembolic events, but underline pathophisiological mechanism still unknown. The strong association between hyperprolactinemia and platelet aggregation is well known. Platelets play a key role in the development of atherothrombosis, a major contribu...

ea0020p445 | Obesity and Metabolism | ECE2009

Effect of metformine treatment on serum paraoxonase and oxidative status in obese women

Fenkci Semin , Karagenc Nedim , Akin Fulya

Objective: To evaluate the effects of metformine newly using in clinical practice to ameliorate insulin resistance on paraoxonase activity and oxidative stress in obese insulin resistant women.Materials and methods: Sixty-seven obese (BMI≥30 kg/m2) women were enrolled into this study. Serum fasting (F.Glc) and postprandial glucose (P.Glc), insulin, uric acid (UA), paraoxonase (PON1), Arylesterase (AET), malondialdehyde (MDA), cupper-MDA ...

ea0020p469 | Obesity and Metabolism | ECE2009

Sexual dysfunction in women with obesity

Yaylali Guzin Fidan , Tekekoglu Selma , Akin Fulya

Objective: Both overweight and obesity have been identified as risk factors for sexual dysfunction in men, but the relationship between female sexual function and amount of body fat is still obscure. To the best of our knowledge there are few reported studies assessing the relation between female sexual function index (FSFI) and body weight in women. Therefore, the aims of this study were to identify the frequency of sexual dysfunction (FSD) among obese women.<p class="abs...

ea0035p264 | Clinical case reports Thyroid/Others | ECE2014

Primary hyperparathyroidism with severe hypercalcemia during pregnancy

Akin Fulya , Erturk Mehmet Sercan , Yaylali Guzin Fidan , Soysal Ergun

Introduction: Primary hyperparathyroidism (PHPT) commonly goes unrecognized due to the physiological changes of pregnancy.PHPT is associated with significant maternal and fetal morbidity and mortality. Current evidence supports parathyroidectomy is the main treatment, performed preferably during the second trimester, when the serum calcium is above 11–mg/dl. We report the clinical course of a woman with newly diagnosed gestational PHPT who refused minimally invasive parat...

ea0022p549 | Neuroendocrinology and Pituitary (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

IGF(CA)19 and IGFBP-3-202A/C gene polymorphism in patients with acromegaly

Akin Fulya , Turgut Sebahat , Cirak Bayram , Kursunluoglu Raziye

Aims: We aimed to investigate IGF1 and IGFBP3 gene polymorphisms in patients with acromegaly.Methods: We included 34 patients with acromegaly and 37 healthy subjects to study. At baseline examinations, antropometric measurements were done. Genomic DNA from the patients and controls were prepared. Serum, glucose, insulin, total cholesterol, triglyceride, HDL-cholesterol, LDL-cholesterol, GH, IGF1 and IGFBP3 levels of subjects were analyzed.<p class="a...

ea0022p550 | Neuroendocrinology and Pituitary (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Angiotensin converting enzyme I/D and M235T angiotensinogen gene polymorphism in patients with acromegaly

Turgut Sebahat , Akin Fulya , Kursunluoglu Raziye , Turgut Gunfer

Background: Acromegaly is associated with increased morbidity and mortality from cardiovascular disease. Hypertension is a number of common cardiovascular risk factors in acromegalic patients. The aim of this study was to investigate association between the frequencies of angiotensin converting enzyme (ACE) I/D and angiotensinogen (AGT) M235T polymorphisms, the genes belongs to the renin–angiotensin–aldosterone system, and clinical parameters of acromegaly patients.<...

ea0020p450 | Obesity and Metabolism | ECE2009

IGF-1 gene polymorphism in obese patients with insulin resistance

Yaylali Guzin Fidan , Akin Fulya , Turgut Sabahat , Kursunluoglu Raziye

Objective: Insulin like growth factors (IGFs) are important regulators of pancreatic β cell devolopment, growth and maintanence. Mutations in the IGF genes have been found to be associated with type 2 diabetes, myocardial infarction, birth weight and obesity. These associations could result from changes in insulin secretion. We aimed to investigate IGF- 1 gene polymorphism in obese patients with insulin resistance.Methods: We included 100 obese pati...

ea0041ep252 | Clinical case reports - Pituitary/Adrenal | ECE2016

Acute myeloid leukemia presenting with panhypopituitarism and diabetes insipidus

Akin Fulya , Erol Veysel , Erturk Sercan , Kiroglu Yilmaz , Topsakal Senay , Yaylali Guzin

Introduction: Acute myeloid leukemia infiltrates the CNS in up to 50% of cases. In contrast, the infiltration of the pituitary gland by leukemia cells is unusual. To date, AML presenting with central diabetes insipidus (CDI) has been rarely reported. Here, we present a patient with AML (subtype clasification is proceeding) presenting with panhypopituitarism and CDI.Case report: A 37-years-old man, with no significant past medical history, presented to Em...

ea0041ep778 | Obesity | ECE2016

Is Pentraxin 3 a marker in pathogenesis of central obesity?

Dedeoglu Ozen , Yaylali Guzin , Akin Fulya , Topsakal Senay , Demir Suleyman , Senol Hande

Introduction: Pentraxin 3 (PTX3) is an acute-phase protein that shares structural homology with C-reactive protein (CRP). PTX3 is produced in macrophages, endothelial cells, and adipocytes in response to inflammatory stimuli, whereas hepatocytes are the main source of CRP. Because obesity and metabolic syndrome (MetS) are considered chronic inflammatory states, PTX3 might be involved in the pathogenesis of obesity and MetS as well as CRP. In this study, we aimed to investigate...